SCHEMBL9449362

SCHEMBL9449362

Nc1ccc(OCCN2C(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.74
NPSR1 Q6W5P4 1/20 0.74
RAB9A P51151 9/20 0.72
NPC1 O15118 4/20 0.72
MAPT P10636 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
ATM Q13315 2/20 0.60
KMT2A Q03164 2/20 0.59
MEN1 O00255 1/20 0.59
GAA P10253 1/20 0.59
TDP1 Q9NUW8 2/20 0.58
POLB P06746 1/20 0.56
APEX1 P27695 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TSHR P16473 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
ALDH1A1 P00352 1/20 0.51
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8487005 0.92 RAB9A (0.77) HPGDNPSR1RAB9ANPC1MAPT
Hydrochloric Acid SCHEMBL8483511 0.91 RAB9A (0.74) HPGDNPSR1RAB9ANPC1MAPT
SCHEMBL8482870 0.91 RAB9A (0.69) HPGDNPSR1RAB9ANPC1MAPT
Amphotalide SCHEMBL1229739 0.89 RAB9A (0.68) HPGDNPSR1RAB9ANPC1MAPT
SCHEMBL31030951 0.87 HPGD (0.79) HPGDNPSR1RAB9ANPC1MAPT
SCHEMBL29237869 0.87 HPGD (0.79) HPGDNPSR1RAB9ANPC1MAPT
SCHEMBL1578469 0.86 RAB9A (0.83) HPGDNPSR1RAB9ANPC1MAPT
SCHEMBL18074274 0.85 HPGD (1.00) HPGDNPSR1RAB9ANPC1MAPT
SCHEMBL1677061 0.84 RAB9A (1.00) HPGDNPSR1RAB9ANPC1MAPT
SCHEMBL8346723 0.84 HPGD (0.74) HPGDNPSR1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5219863-A Treating hypertension and congestive heat failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-06-15 US disclosed
EP-0487252-A1 Quinoline and 1,5-Naphthyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them ZENECA LIMITED (GB) 1992-05-27 EP disclosed